Solvang Genetics ApS: Financial statements 2023
CVR: 42924911
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Solvang Genetics ApS (CVR 42924911) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 7,947,192 and a net result of DKK 2,317,797 compared with DKK -826,887 the year before. That is an increase of 938.3% compared with the year before. Equity in the 2023 report amounted to DKK 1,530,910. The solvency ratio was 7.5%. The company had 10 employees in the financial year.
- Gross Profit
- DKK 7,947,192
- Profit/Loss
- DKK 2,317,797
- Equity
- DKK 1,530,910
- Total Assets
- DKK 20,391,956
- Employees
- 10
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 7.9 mio. | 2.3 mio. | 1.5 mio. | 10 |
| 2022 | - | 765 t. | -827 t. | -787 t. | 0 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Solvang Genetics ApS has published its annual report for 2022. Gross profit came to DKK 765,376, and the net result was DKK -826,887.
About Solvang Genetics ApS
Solvang Genetics ApS was a Danish company of the type Anpartsselskab based in Eskebjerg, founded in 2021. The company has been dissolved on 3 August 2026. The company was registered under the industry Avl af smågrise. The company has 9 employees (2026). In 2025, the company reported a gross profit of DKK 4,497,931 and a net result of DKK 1,758,924 compared with DKK 358,070 the year before. Equity in the 2025 report amounted to DKK 14,241,161.